1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > United States Immuno Chemistry Market Outlook to 2021

United States Immuno Chemistry Market Outlook to 2021

  • August 2015
  • -
  • Global Data
  • -
  • 104 pages

United States Immuno Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, "United States Immuno Chemistry Market Outlook to 2021", provides key market data on the United States Immuno Chemistry market. The report provides value, in millions of US dollars within market segments - Anemia Tests, Vitamins Tests, Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC, IgE Allergy Blood Tests and Specific Proteins.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Immuno Chemistry market includes Anemia Tests, Vitamins Tests, Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC, IgE Allergy Blood Tests and Specific Proteins.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Immuno Chemistry market.
- Global corporate-level profiles of key companies operating within the United States Immuno Chemistry market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Alere Inc., Ortho-Clinical Diagnostics Inc. and Abbott Laboratories.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

United States Immuno Chemistry Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Immuno Chemistry Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Immuno Chemistry Market, United States 13
3.1 Immuno Chemistry Market, United States, Revenue ($m), 2007-2014 13
3.2 Immuno Chemistry Market, United States, Revenue ($m), 2014-2021 15
3.2.1 Anemia Tests Market, United States, Revenue ($m), by Segment, 2007-2014 17
3.2.2 Disease Specific Immunochemistry Market, United States, Revenue ($m), by Segment, 2007-2014 19
3.2.3 Endocrinology Tests Market, United States, Revenue ($m), by Segment, 2007-2014 21
3.2.4 IgE Allergy Blood Tests Market, United States, Revenue ($m), by Segment, 2007-2014 23
3.2.5 Immunochemistry Analyzers Market, United States, Revenue ($m), by Segment, 2007-2014 25
3.2.6 Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), by Segment, 2007-2014 27
3.2.7 Vitamins Tests Market, United States, Revenue ($m), by Segment, 2007-2014 29
3.2.8 Anemia Tests Market, United States, Revenue ($m), by Segment, 2014-2021 31
3.2.9 Disease Specific Immunochemistry Market, United States, Revenue ($m), by Segment, 2014-2021 33
3.2.10 Endocrinology Tests Market, United States, Revenue ($m), by Segment, 2014-2021 35
3.2.11 IgE Allergy Blood Tests Market, United States, Revenue ($m), by Segment, 2014-2021 37
3.2.12 Immunochemistry Analyzers Market, United States, Revenue ($m), by Segment, 2014-2021 39
3.2.13 Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), by Segment, 2014-2021 41
3.2.14 Vitamins Tests Market, United States, Revenue ($m), by Segment, 2014-2021 43
3.3 Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2013-2014 45
3.4 Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2014 46
4 Overview of Key Companies in United States, Immuno Chemistry Market 48
4.1 Siemens Healthcare 48
4.1.1 Company Overview 48
4.2 F. Hoffmann-La Roche Ltd. 48
4.2.1 Company Overview 48
4.3 Thermo Fisher Scientific Inc. 48
4.3.1 Company Overview 48
4.4 Alere Inc. 49
4.4.1 Company Overview 49
4.5 Ortho-Clinical Diagnostics Inc. 49
4.5.1 Company Overview 49
4.6 Abbott Laboratories 49
4.6.1 Company Overview 49
4.7 PerkinElmer, Inc. 50
4.7.1 Company Overview 50
4.8 Danaher Corporation 50
4.8.1 Company Overview 50
4.9 bioMerieux S.A. 50
4.9.1 Company Overview 50
4.10 Bio-Rad Laboratories, Inc. 51
4.10.1 Company Overview 51
5 Immuno Chemistry Market Pipeline Products 52
6 Financial Deals Landscape 58
6.1 Acquisition 58
6.1.1 Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion 58
6.1.2 Eurofins Scientific Acquires Boston Heart Diagnostics 61
6.1.3 Optum to Acquire Alere for USD600 Million 63
6.1.4 Sigma-Aldrich Acquires Cell Marque 65
6.1.5 Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion 66
6.1.6 Nanosphere Plans to Sell Itself 67
6.2 Debt Offerings 68
6.2.1 Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 68
6.2.2 Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 70
6.2.3 Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 72
6.3 Equity Offerings 74
6.3.1 CombiMatrix to Raise USD5 Million in Private Placement of Securities 74
6.3.2 CombiMatrix to Raise USD3 Million in Private Placement of Warrants 77
6.3.3 Nanosphere Terminates Private Placement of Shares for USD30 Million 79
6.4 Partnerships 80
6.4.1 Anixa Diagnostics Enters into Research Agreement with Wistar Institute 80
6.4.2 Propanc Health Enters into Research Agreement with Adaptive Biotech 81
6.4.3 Merck Serono Enters into Co- Development Agreement with Illumina 82
6.4.4 Qiagen Enters into Co-Development Agreement with Astellas Pharma 84
6.4.5 Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 86
6.4.6 Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 87
6.4.7 Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 88
6.4.8 Tufts Medical Center Forms Joint Venture with Aton Partners 89
6.4.9 Regulus Therapeutics Enters into Agreement with Biogen Idec for microRNA Biomarkers 90
6.5 Venture Financing 91
6.5.1 Inform Genomics Raises USD2.6 Million in Venture Financing 91
6.5.2 Diagnostic BioSystems Raises Funds through Venture Financing 92
6.5.3 Lucigen Raises USD2.2 Million in Venture Financing 93
6.5.4 Accriva Diagnostics Raises USD15.5 Million in Venture Financing 94
6.5.5 Exosome Diagnostics to Raise USD25 Million in Venture Financing 95
6.5.6 Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 96
6.5.7 ImmusanT Raises USD12 Million Series B Venture Financing 97
6.5.8 BioMedomics Raises USD0.3 Million in Venture Financing 98
6.5.9 Nanovi Raises USD3.4 Million in Venture Financing 99
6.5.10 Avelas Biosciences Raises USD0.5 Million in Second Tranche of Series B Financing 100
7 Appendix 101
7.1 Research Methodology 102
7.1.1 Coverage 102
7.1.2 Secondary Research 102
7.1.3 Primary Research 102
7.1.4 Company Share Analysis 103
7.1.5 Distribution Share Analysis 103
7.2 GlobalData Consulting 103
7.3 Contact Us 103
7.4 Disclaimer 104

1.1 List of Tables
Table 1: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 2: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 16
Table 3: Anemia Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 4: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 20
Table 5: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 22
Table 6: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 24
Table 7: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 26
Table 8: Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 28
Table 9: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 30
Table 10: Anemia Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Table 11: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 34
Table 12: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 36
Table 13: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Table 14: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 40
Table 15: Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 42
Table 16: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 44
Table 17: Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 45
Table 18: Immuno Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2014 47
Table 19: Immuno Chemistry Market Pipeline Products 52
Table 20: Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion 58
Table 21: Eurofins Scientific Acquires Boston Heart Diagnostics 61
Table 22: Optum to Acquire Alere for USD600 Million 63
Table 23: Sigma-Aldrich Acquires Cell Marque 65
Table 24: Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion 66
Table 25: Nanosphere Plans to Sell Itself 67
Table 26: Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 68
Table 27: Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 70
Table 28: Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 72
Table 29: CombiMatrix to Raise USD5 Million in Private Placement of Securities 74
Table 30: CombiMatrix to Raise USD3 Million in Private Placement of Warrants 77
Table 31: Nanosphere Terminates Private Placement of Shares for USD30 Million 79
Table 32: Anixa Diagnostics Enters into Research Agreement with Wistar Institute 80
Table 33: Propanc Health Enters into Research Agreement with Adaptive Biotech 81
Table 34: Merck Serono Enters into Co- Development Agreement with Illumina 82
Table 35: Qiagen Enters into Co-Development Agreement with Astellas Pharma 84
Table 36: Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 86
Table 37: Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 87
Table 38: Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 88
Table 39: Tufts Medical Center Forms Joint Venture with Aton Partners 89
Table 40: Regulus Therapeutics Enters into Agreement with Biogen Idec for microRNA Biomarkers 90
Table 41: Inform Genomics Raises USD2.6 Million in Venture Financing 91
Table 42: Diagnostic BioSystems Raises Funds through Venture Financing 92
Table 43: Lucigen Raises USD2.2 Million in Venture Financing 93
Table 44: Accriva Diagnostics Raises USD15.5 Million in Venture Financing 94
Table 45: Exosome Diagnostics to Raise USD25 Million in Venture Financing 95
Table 46: Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 96
Table 47: ImmusanT Raises USD12 Million Series B Venture Financing 97
Table 48: BioMedomics Raises USD0.3 Million in Venture Financing 98
Table 49: Nanovi Raises USD3.4 Million in Venture Financing 99
Table 50: Avelas Biosciences Raises USD0.5 Million in Second Tranche of Series B Financing 100

1.2 List of Figures
Figure 1: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 2: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Figure 3: Anemia Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 4: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 19
Figure 5: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 21
Figure 6: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 23
Figure 7: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 25
Figure 8: Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 27
Figure 9: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 29
Figure 10: Anemia Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Figure 11: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 33
Figure 12: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 35
Figure 13: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Figure 14: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Figure 15: Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 41
Figure 16: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 43
Figure 17: Immuno Chemistry Market, United States, Company Share (%) 2014 46

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.